About me
Keith Kowalczyk, MD, is the Physician Executive Director, MedStar Health Urology and the Chair, Department of Urology at MedStar Georgetown University Hospital. He is board certified in urology, with training in urologic oncology and robotic-assisted surgery. He sees patients at MedStar's Pasquerilla Healthcare Center at MedStar Georgetown in Washington, D.C., as well as MedStar's clinic in Chevy Chase.
Dr. Kowalczyk treats a full range of urologic conditions, but focuses on kidney, testicular, bladder, and prostate cancers. While skilled in performing traditional open surgery, his special expertise is in robotic-assisted surgery, and he has performed hundreds of procedures using this technology.
Dr. Kowalczyk is one of the few urologic surgeons in the D.C. metro area with specific expertise and training in urologic robotic surgery for urologic cancers. For those not familiar with robotic surgery, the surgeon uses special instruments controlled through a robotic/computer console which allows increased range of motion and often more precision than traditional surgical instruments. The camera he uses provides 10 to 12 times more magnification than traditional cameras used in surgery.
With his experience in performing robotic surgery, Dr. Kowalczyk is able to perform a more precise surgery with generally fewer complications. Also, Dr. Kowalczyk is able to offer more options for certain high-risk patients, like obese men who need prostatectomy surgery as well as patients with large kidney masses who have been told their kidney requires removal. With the magnified view and precision of robotic surgery, these patients have the options of minimally invasive procedures and better outcomes.
Dr. Kowalczyk is also actively involved in health services research on cancer treatments, outcomes, and patterns and costs of care and has authored numerous peer-reviewed articles on these topics.
Clinical areas of focus
- Bladder Cancer
- Bph Surgery
- Elevated Psa
- Hematuria
- Kidney Cancer
- Prostate Cancer
Conditions and procedures
Conditions I treat
- Adenocarcinoma Of The Bladder
- Adrenal Neoplasm
- Adrenal Nodules
- Benign Prostatic Hyperplasia
- Bladder Cancer
- Elevated Psa
- Familial Renal Cell Carcinoma
- Genitourinary Cancers
- Hematuria
- Hereditary Kidney Cancer
- Hydronephrosis
- Hydroureter
- Kidney Cancer
- Localized Prostate Cancer
- Malignancies Of The Genitourinary System
- Malignant Carcinoid Tumor Of Kidney
- Malignant Neoplasm Of Ureter
- Malignant Neoplasm Of Ureteric Orifice
- Malignant Tumor Of Renal Pelvis
- Metastatic Prostate Cancer
- Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Cancer
- Penile Cancer
- Priapism
- Prostate Cancer
- Renal Mass
- Renal Pelvis Carcinoma
- Renal Sarcoma
- Retroperitoneal Sarcoma
- Seminoma
- Squamous Cell Carcinoma Of Bladder
- Testicular Cancer
- Testicular Choriocarcinoma
- Transitional Cell Carcinoma
- Upper Tract Urothelial Cancer
- Urachal Cancer
- Ureteropelvic Junction Obstruction
Procedures I perform
- Active Surveillance Of Prostate Cancer
- Bladder Cancer Surgery
- Blue Light Cystoscopy With Cysview
- Bph Surgery
- Continent Urinary Diversion
- Cystectomy
- Da Vinci
- Da Vinci Adrenalectomy
- Da Vinci Prostatectomy
- Endoscopic Surgery For Bladder Cancer
- Focal Therapy For Prostate Cancer
- Genitourinary Cancer Surgery
- Gleason Score
- High Intensity Focus Ultrasound For Prostate Cancer
- Ileal Conduit
- Intravesical Chemotherapy
- Kidney Cancer Surgery
- Kidney Surgery
- Laparoscopic Radical Prostatectomy
- Laparoscopic Surgery For Bladder Cancer
- Laparoscopic Surgery For Kidney Cancer
- Laparoscopic Surgery For Prostate Cancer
- Laparoscopic Urology
- Lymph Node Dissection
- Mri Ultrasound Fusion Imaging Of The Prostate
- Neobladder Construction
- Nephrectomy
- Nephroureterectomy
- Nerve-Sparing Retroperitoneal Lymph Node Dissection
- Orchiectomy
- Partial Cystectomy
- Partial Nephrectomy
- Partial Orchiectomy
- Pelvic Surgery
- Post-Chemotherapy Retroperitoneal Lymph Node Dissection
- Prostate Biopsy
- Prostate Cancer Screening
- Prostate Cancer Surgery
- Prostate Imaging
- Prostate Needle Biopsy
- Prostate Specific Antigen Blood Test
- Prostatectomy
- Pyeloplasty
- Radical Inguinal Orchiectomy
- Radical Prostatectomy
- Robotic Bladder Surgery
- Robotic Prostate Surgery
- Robotic Pyeloplasty
- Robotic Surgery For Bladder Cancer
- Robotic Surgery For Kidney Cancer
- Robotic Surgery For Prostate Cancer
- Salvage Prostatectomy
- Screening For Malignant Neoplasms Of Prostate
- Testicular Cancer Surgery
- Transurethral Prostatectomy
- Transurethral Resection Of Bladder
- Ureterectomy
- Urinary Diversion
Practice locations
Distance from Change LocationEnter your Location
3800 Reservoir Road Northwest HealthCare Center 3rd Fl Washington, DC, 20007
202-444-4922Fax 877-625-1478
Insurance
MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.
-
List of insurance plans we accept
- Carefirst BlueChoice Opt Out Plus Open Access (POS)
- Carefirst BlueChoice HMO
- Veterans Affairs Community Care Network
- United Group Medicare Advantage Plans
- HumanaChoice PPO
- Federal Employee Program (Std/Basic PPO/Blue Focus)
- Cigna POS/Network POS
- Virginia Premier
- United Optimum Choice Preferred (POS) & OCI Direct (HMO)
- Aetna HMO
- Beech Street PPO
- UnitedHealthcare Individual Exchange Plans
- Carefirst Healthy Blue (HMO/POS)
- Cigna POS Open Access & Open Access Plus
- Aetna Choice POS & Choice POS II
- Medicaid - Virginia
- Innovation Health: Network Only Plus
- Innovation Health: Open Network Only Plus
- United Select Plus (POS)
- MedStar Family Choice DC Healthcare Alliance
- Kaiser Select-Added Choice
- Innovation Health: Open POS II
- Aetna Managed Choice Open Access (POS)
- Priority Partners - Maryland Health Choice
- United Community Plan - Maryland Health Choice Program
- United Choice
- United Nursing Home Plan (C-SNP
- Medicaid - Maryland
- Cigna Preferred Medicare
- CareFirst MedStar PPO
- Innovation Health: Open POS Plus
- United Options (PPO) (includes Empire PPO)
- Aetna Elect Choice/ Open Access (POS)
- I-SNP
- Innovation Health: HMO & EPO Plus
- United Select HMO - EPO/NPP
- Cigna Network Open Access
- United Navigate
- CareFirst Blue Card Program (Out-of-area BCBS plans)
- United MD IPA Preferred (POS)
- United Choice Plus
- Health Services for Children with Special Needs (HSCSN)
- Aetna HMO-Open Access/Select OA
- Cigna Indemnity
- CareFirst NASCO
- United Mamsi Life & Health
- Kaiser Select
- Police and Fire Clinic
- CareFirst (NCA) Indemnity
- Aetna Open HMO/Open HMO Option/Open EPO Plus
- Cigna EPO
- CareFirst Administrators
- Cigna Achieve Medicare (HMO C-SNP)
- Aetna Managed Choice (POS)
- Cigna True Choice Medicare (PPO)
- Uniformed Services Family Health Plan (USFHP)
- United Optimum Choice
- Innovation Health: POS
- CareFirst Group Medicare Advantage prescription drug benefit (PPO)
- Tricare for Life East
- Maryland Point of Service Plan (MPOS)
- Aetna Elect Choice/ EPO (Aetna Health Fund)
- Cigna HMO Open Access
- Kaiser Signature
- Traditional Medicare Fee for Service
- CareFirst MedStar Select PPO
- Carefirst BlueChoice Open Access
- Employee Health Plan (EHP)
- United Medicare Advantage DSNP District of Columbia
- United MD IPA (HMO)
- Tricare East Select
- Carefirst Blue Preferred PPO
- Carefirst BlueChoice Opt Out Open Access
- United Core Essential (HMO)
- CareFirst Maryland Indemnity or PPO
- Kaiser HMO Plus and DHMO Plus Member
- Cigna Alliance Medicare (HMO) |
- Aetna HealthFund/Health Network Option OA
- MedStar Family Choice DC Healthy Families
- CareFirst Group Medicare Advantage
- United GEHA (for all other states) Compass Rose
- Medicaid - District of Columbia
- Aetna Medicare Advantage HMO & PPO Plans
- Aetna Traditional Choice (PPO)
- Innovation Health: PPO
- CareFirst BC/BS Advantage Core/Enhanced
- Carefirst EPO
- HumanaChoice Honor’s plan PPO
- WellPoint Maryland
- United Golden Rule
- Aetna Student Health Insurance
- Veterans Affairs Community Care Network (VA CCN)
- United Student Resources
- Cigna PPO and PPO Plus
- Private Health Care Systems (PHCS) (PPO)
- Cigna True Choice Plus Medicare (PPO)
- Cigna HMO & Network (HMO)
- Coventry Health Care National Network PPO
- MedStar Family Choice - Maryland Health Choice
- First Health PPO
- Coventry of Delaware HMO/PPO
- Coventry Health Care of Virginia
- Great-West Healthcare POS/CIGNA
- Kaiser Medicare Advantage Signature and Select
- Cigna Choice Fund PPO
- Tricare East Prime
- Kaiser Flexible Choice
- Innovation Health: POS Plus
- Innovation Health: Indemnity
- Aetna Signature Administrator PPO/TPA
- Kaiser Medicare Plus
- WellPoint Maryland - Maryland Health Choice
- Tricare Reserve Select
- Aetna Select HMO/HealthFund/Health Network
- United Erickson Advantage Plans
- Aetna Quality Point of Service (POS)
- Cigna TotalCare (HMO D-SNP)
- Kaiser Permanente Signature-Added Choice
- United AARP Medicare Complete
- HealthyBlue PPO
- Aetna Open Choice (PPO)
- D-SNP)
Videos
Education
Board Certification: American Board of Urology, Urology
Fellowship: Brigham and Women's Hospital (2011)
Residency: Georgetown University Hospital (2010)
Medical School: Georgetown University (2005)
Awards
- Faculty Teacher of the Year Award, Georgetown University/Washington Hospital Center Urology Residency Program (2015)
- Resident Teacher Award, Department of Urology. Georgetown University Hospital (2010)
- String of Pearls Finalist, Best Resident Teacher, Georgetown University Hospital (2010)
- 3rd Place, Resident Research Presentation, Washington Urologic Society (2008)
Hospital affiliations
News and publications
Complex space of Retzius lymphocele resulting in iliac compression and submassive pulmonary embolism after robotic Retzius sparing prostatectomy. C Goldman, CP Dall, T Sholklapper, J Brems, K Kowalczyk. Urology Case Reports, epub, 2021.
Retzius-Sparing Robot-Assisted Robotic Prostatectomy: Past, Present, and Future
M Davis, J Egan, S Marhamati, A Galfano, KJ Kowalczyk. Urologic Clinics 48 (1), 11-23, 2021.
Impact of Retzius-sparing Versus Standard Robotic-assisted Radical Prostatectomy on Penile Shortening, Peyronie’s Disease, and Inguinal Hernia Sequelae. KJ Kowalczyk, M Davis, J O’Neill, H Lee, J Orzel, RS Rubin, JC Hu. European Urology Open Science 22, 17-22
Sex and Racial Disparities in the Treatment and Outcomes of Muscle-Invasive Bladder Cancer. Marinaro J, Zeymo A, Carvalho F, Krasnow R, Egan JE, Stamatakis L, Lynch JH, Hwang J,
Williams SB, Kowalczyk KJ. Urology, in press, 2020.
Retzius-sparing robot-assisted radical prostatectomy leads to durable improvement in urinary function and quality of life versus standard robot-assisted radical prostatectomy without compromise of oncologic efficacy: single surgeon series and step-by-step guide. Egan J, Marhamati S, Carvalho F, Davis M, O’Neill J, Lee H, Lynch JH, Hankins RA, Hu JC, Kowalczyk KJ. European Urology, Epub ahead of print June 11 2020.
Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer.
Carvalho FL, Zeymo A, Egan J, Kelly CH, Zheng C, Lynch JH, Hwang J, Stamatakis L, Krasnow RE, Kowalczyk KJ. Investig Clin Urol, 61(4):390-396, July 2020
Prostate Cancer in Men With Treated Advanced Heart Failure: Should we Keep Screening?
Lee HH, Shaw NM, Mohammed S, Kowalczyk KJ, Stamatakis L, Krasnow RE.
Urology. 2020 Feb;136:46-50.
Complications associated with perioperative use of tyrosine kinase inhibitors and cytoreductive nephrectomy. Carvalho FL, Zheng C, Witmer K, O’Neill J, Lynch JH, Krasnow R, Stamatakis L, Kowalczyk KJ. Sci Rep. 2019 Oct 24;9(1):15272.
Fidelity of a PDX-CR model for bladder cancer. Mondal AM, Ma AH, Li G, Krawczyk E, Yuan R, Lu J, Schlegel R, Stamatakis L, Kowalczyk KJ, Philips GK, Pan CX, Liu X. Biochem Biophys Res Commun. 2019 Sep 10;517(1):49-56
Survival and secondary interventions following treatment for locally-advanced prostate cancer. Sussman R, Carvalho FL, Harbin A, Zheng C, Lynch JH, Stamatakis L, Hwang J, Williams SB, Hu JC, Kowalczyk KJ. Canadian Journal of Urology, October 2018, 25 (5): 9425-9433.
Utilization and predictors of expectant management among elderly men with low-and intermediate-risk localized prostate cancer in U.S. urological practice. Tsai HT, Philips G, Taylor KL, Kowalczyk KJ, Huai-Ching K, Potosky A. Urol Pract. 2017 Mar;4(2):132-139
Giant renal oncocytoma with classic stellate scar. Sussman RD, Kowalczyk KJ. BMJ Case Rep, Jan 2017, http://casereports.bmj.com/content/2017/bcr-2016-218944.
Transobturator sling for post-prostatectomy incontinence: radiation’s effect on efficacy and satisfaction. Wright HC, McGeagh K, Richter LA, Hwang JJ, Venkatesen K, Pysher A, Koch GE, Kowalczyk KJ, Bandi G, Marchalik D. Canadian Journal of Urology 2017, 24 (5), 8998-9002.
Single-center, FDA approved, prospective evaluation of the safety and efficacy of PAE for LUTS from BPH. Kim A, Kowalczyk KJ, Lynch J, Spies J. Journal of Vascular and Interventional Radiology 2017, 2 (28), S115-S116.
Perioperative outcomes of robotic and laparoscopic simple prostatectomy: a European-American multi-institutional analysis. Autorino R, Zargar H, Mariano MB, Kowalczyk KJ, et al. European Urology. July 2015 68:1: 86-94.
The burden of skeletal-related events in patients with prostate cancer and bone metastasis. Roghmann F, Antczak C, McKay RR, Choueiri T, Hu JC, Kibel AS, Kim SP, Kowalczyk KJ, Menon M, Nguyen PL, Saad F, Sammon JD, Schmid M, Sukumar S, Sun M, Noldus J, Trinh QD. Urol Oncol. 2015 Jan;33(1):17. e9-18.
Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer. Arscott WT, Chen LN, Wilson N, Bhagat A, Kim JS, Moures RA, Yung TM, Lei S, Collins BT, Kowalczyk K, Suy S, Dritschilo A, Lynch JH, Collins SP. Radiat Oncol. 2014 Jul 24; 9:163
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer. Chen LN, Suy S, Wang H, Bhagat A, Woo JA, Moures RA, Kim JS, Yung TM, Lei S, Collins BT, Kowalczyk K, Dritschilo A, Lynch JH, Collins SP. Radiat Oncol. 2014 Jun 26; 9:148
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies. Chen LN, Rubin RS, Othepa E, Cer C, Yun E, Agarwal RP, Collins BT, McGeagh K, Pahira J, Bandi G, Kowalczyk K, Kumar D, Dritschilo A, Collins SP, Bostwick DG, Lynch JH, Suy S. Prostate. 2014 May;74(7):714-21.
Multi-institutional outcomes and cost effectiveness of using alvimopan to lower gastrointestinal morbidity after cystectomy and urinary diversion. Vora A, Marchalik D, Nissim H, Kowalczyk K, Bandi G, McGeagh K, Lynch J, Venkatesan K, Ghasemian R, Hwang J, Hwang MV. Can J Urol. 2014 Apr;21(2):7222-7
Is there any evidence of a "July effect" in patients undergoing major cancer surgery?
Ravi P, Trinh VQ, Sun M, Sammon J, Sukumar S, Gervais MK, Shariat SF, Kim SP, Kowalczyk KJ, Hu JC, Menon M, Karakiewicz PI, Trinh QD. Can J Surg. 2014 Apr;57(2):82-8.
Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer. Kowalczyk KJ, Gu X, Nguyen PL, Lipsitz SR, Trinh QD, Lynch JH, Collins SP, Hu JC. Urol Oncol. 2014 Apr;32(3):303-8. doi: 10.1016/j.urolonc.2013.09.004.
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer. Bhattasali O, Chen LN, Woo J, Park JW, Kim JS, Moures R, Yung T, Lei S, Collins BT, Kowalczyk K, Suy S, Dritschilo A, Lynch JH, Collins SP. Radiat Oncol. 2014 Feb 11; 9:52.
Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. Trinh VQ, Karakiewicz PI, Sammon J, Sun M, Sukumar S, Gervais MK, Shariat SF, Tian Z, Kim SP, Kowalczyk KJ, Hu JC, Menon M, Trinh QD. JAMA Surg. 2014 Jan;149(1):43-9.
Potency preservation following stereotactic body radiation therapy for prostate cancer. Obayomi-Davies O, Chen LN, Bhagat A, Wright HC, Uhm S, Kim JS, Yung TM, Lei S, Batipps GP, Pahira J, McGeagh KG, Collins BT, Kowalczyk K, Bandi G, Kumar D, Suy S, Dritschilo A, Lynch JH, Collins SP. Radiat Oncol. 2013 Nov 1; 8:256
Robotic-assisted prostatectomy and open radical retropubic prostatectomy for locally-advanced prostate cancer: multi-institution comparison of oncologic outcomes. Vora AA, Marchalik D, Kowalczyk KJ, Nissim H, Bandi G, McGeagh KG, Lynch JH, Ghasemian SR, Verghese M, Venkatesan K, Borges P, Uchio EM, Hwang JJ. Prostate Int. 2013;1(1):31-6.
Incidence and treatment patterns in males presenting with lower urinary tract symptoms to the emergency department in the United States. Roghmann F, Ghani KR, Kowalczyk KJ, Bhojani N, Sammon JD, Gandaglia G, Trudeau V, Becker A, Sukumar S, Menon M, Zorn KC, Karakiewicz P, Sun M, Noldus J, Trinh QD. J Urol. 2013 Nov;190(5):1798-804.
Use of surveillance imaging following treatment of small renal masses.
Kowalczyk KJ, Harbin AC, Choueiri TK, Hevelone ND, Lipsitz SR, Trinh QD, Tina Shih YC, Hu JC. J Urol. 2013 Nov;190(5):1680-5. doi: 10.1016/j.juro.2013.05.109.
Predictors of Gleason score upgrading in a large African-American population. Vora A, Large T, Aronica J, Haynes S, Harbin A, Marchalik D, Nissim H, Lynch J, Bandi G, McGeagh K, Kowalczyk K, Ghasemian R, Venkatesan K, Verghese M, Hwang J. Int Urol Nephrol. 2013 Oct;45(5):1257-62
Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy. Kaplan JR, Kowalczyk KJ, Borza T, Gu X, Lipsitz SR, Nguyen PL, Friedlander DF, Trinh QD, Hu JC. BJU Int. 2013 Jun;111(8):1208-14.
Health care-associated infections after major cancer surgery: temporal trends, patterns of care, and effect on mortality. Sammon J, Trinh VQ, Ravi P, Sukumar S, Gervais MK, Shariat SF, Larouche A, Tian Z, Kim SP,Kowalczyk KJ, Hu JC, Menon M, Karakiewicz PI, Trinh QD, Sun M. Cancer. 2013 Jun 15;119(12):2317-24.
The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy. Trinh QD, Sun M, Kim SP, Sammon J, Kowalczyk KJ, Friedman AA, Sukumar S, Ravi P, Muhletaler F, Agarwal PK, Shariat SF, Hu JC, Menon M, Karakiewicz PI. Urol Oncol. 2014 Jan;32(1):29. e13-20.
Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007. Kowalczyk KJ, Choueiri TK, Hevelone ND, Trinh QD, Lipsitz SR, Nguyen PL, Lynch JH, Hu JC. BJU Int. 2013 Aug;112(4): E273-80.
Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States. Sammon JD, Ghani KR, Karakiewicz PI, Bhojani N, Ravi P, Sun M, Sukumar S, Trinh VQ,Kowalczyk KJ, Kim SP, Peabody JO, Menon M, Trinh QD. Eur Urol. 2013 Jul;64(1):85-92.
Effect of minimizing tension during robotic-assisted laparoscopic radical prostatectomy on urinary function recovery. Kowalczyk KJ, Huang AC, Hevelone ND, Lipsitz SR, Yu HY, Lynch JH, Hu JC. World J Urol. 2013 Jun;31(3):515-21.
Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience. Chen LN, Suy S, Uhm S, Oermann EK, Ju AW, Chen V, Hanscom HN, Laing S, Kim JS, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Dawson NA, Taylor KL, Dritschilo A, Lynch JH, Collins SP. Radiat Oncol. 2013 Mar 13; 8:58.
Anatomic and technical considerations for optimizing recovery of urinary function during robotic-assisted radical prostatectomy. Vora AA, Dajani D, Lynch JH, Kowalczyk KJ.
Curr Opin Urol. 2013 Jan;23(1):78-87.
Influence of surgeon and hospital volume on radical prostatectomy costs.
Williams SB, Amarasekera CA, Gu X, Lipsitz SR, Nguyen PL, Hevelone ND, Kowalczyk KJ, Hu JC. J Urol. 2012 Dec;188(6):2198-202.
Factors associated with the adoption of minimally invasive radical prostatectomy in the United States. Ulmer WD, Prasad SM, Kowalczyk KJ, Gu X, Dodgion C, Lipsitz S, Palapattu GS, Choueiri TK, Hu JC. J Urol. 2012 Sep;188(3):775-80.
Morbidity and costs of salvage vs. primary radical prostatectomy in older men. Prasad SM, Gu X, Kowalczyk KJ, Lipsitz SR, Nguyen PL, Hu JC. Urol Oncol. 2013 Nov;31(8):1477-82.
Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Yu HY, Hevelone ND, Lipsitz SR, Kowalczyk KJ, Nguyen PL, Choueiri TK, Kibel AS, Hu JC. Eur Urol. 2012 Jun;61(6):1239-44.
Alemozaffar M, Duclos A, Hevelone ND, Lipsitz SR, Borza T, Yu HY, Kowalczyk KJ, Hu JC. Eur Urol. 2012 Jun;61(6):1222-8.
Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy. Yu HY, Hevelone ND, Lipsitz SR, Kowalczyk KJ, Nguyen PL, Hu JC.
J Urol. 2012 May;187(5):1632-7.
Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery. Yu HY, Hevelone ND, Lipsitz SR, Kowalczyk KJ, Hu JC.J Urol. 2012 Apr;187(4):1392-8.
Temporal national trends of minimally invasive and retropubic radical prostatectomy outcomes from 2003 to 2007: results from the 100% Medicare sample. Kowalczyk KJ, Levy JM, Caplan CF, Lipsitz SR, Yu HY, Gu X, Hu JC. Eur Urol. 2012 Apr;61(4):803-9.
Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer.
Williams SB, Lei Y, Nguyen PL, Gu X, Lipsitz SR, Yu HY, Kowalczyk KJ, Hu JC.
BJU Int. 2012 Jul;110(2 Pt 2):E92-8.
Partial clamping of the renal artery during robot-assisted laparoscopic partial nephrectomy: technique and initial outcomes. Kowalczyk KJ, Alemozaffar M, Hevelone ND, Ulmer WD, Plaster BA, Lipsitz SR, Yu HY, Hu JC. J Endourol. 2012 May;26(5):469-73.
Comparison of outpatient narcotic prescribing patterns after minimally invasive versus retropubic and perineal radical prostatectomy. Kowalczyk KJ, Weinburg AC, Gu X, Yu HY, Lipsitz SR, Williams SB, Hu JC. J Urol. 2011 Nov;186(5):1843-8.
Stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: technique and outcomes. Kowalczyk KJ, Huang AC, Hevelone ND, Lipsitz SR, Yu HY, Ulmer WD, Kaplan JR, Patel S, Nguyen PL, Hu JC.
Eur Urol. 2011 Sep;60(3):536-47.
Challenges of interpreting and improving radical prostatectomy outcomes: technique, technology, training, and tactical reporting. Hu JC, Yu HY, Kowalczyk KJ.
Eur Urol. 2011 Jun;59(6):1073-4.
Outcomes assessment in men undergoing open retropubic radical prostatectomy, laparoscopic radical prostatectomy, and robotic-assisted radical prostatectomy. Kowalczyk KJ, Yu HY, Ulmer W, Williams SB, Hu JC. World J Urol. 2012 Feb;30(1):85-9.
Health services research in urology. Yu HY, Ulmer W, Kowalczyk KJ, Hu JC. World J Urol. 2011 Jun;29(3):273-6.
The impact of prostate size, median lobe, and prior benign prostatic hyperplasia intervention on robot-assisted laparoscopic prostatectomy: technique and outcomes. Huang AC, Kowalczyk KJ, Hevelone ND, Lipsitz SR, Yu HY, Plaster BA, Amarasekara CA, Ulmer WD, Lei Y, Williams SB, Hu JC. Eur Urol. 2011 Apr;59(4):595-603.
Lei Y, Alemozaffar M, Williams SB, Hevelone N, Lipsitz SR, Plaster BA, Amarasekera CA, Ulmer WD, Huang AC, Kowalczyk KJ, Hu JC. Eur Urol. 2011 Feb;59(2):235-43.
Partial nephrectomy after previous radio frequency ablation: The National Cancer Institute experience. Kowalczyk KJ, Hooper HB, Linehan WM, Pinto PA, Wood BJ, Bratslavsky G. J Urol. 2009 Nov;182(5):2158-63.
Abstracts
Retzius-Sparing Robotic Radical Prostatectomy Shortened Recovery of Patient Continence Without Compromise of Oncologic Outcomes. O’Neill JW, Carvalho F, Lee H, Egan J, Shaw N, Lynch JH, Holzman S, Witmer K, Wright HC, Kowalczyk KJ. Accepted, Podium Presentation, MAAUA Annual Meeting, Pocono Manor PA, October 2019.
Gender and racial disparities in the treatment and outcomes of muscle invasive bladder cancer. Marinaro J, Egan J, Carvalho F, Zeymo A, Stamatakis L, Krasnow R, Kowalczyk KJ. Accepted, Resident Prize Essay Podium Presentation, MAAUA Annual Meeting, Pocono Manor PA, October 2019.
Delays from diagnosis to radical cystectomy are associated with worse survival in muscle-invasive bladder cancer. Carvalho F, Zeymo A, Shaw N, Egan J, Stamatakis L, Krasnow RE, Lynch JH, Kowalczyk KJ. Accepted, Podium Presentation, MAAUA Annual Meeting, Pocono Manor PA, October 2019.
Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer: results from the National Cancer Database. Carvalho F, Kelly C, Zeymo A, Zheng C, Stamatakis L, Krasnow R, Kowalczyk KJ. Resident Prize Essay, 3rd Prize, MAAUA Annual Meeting, Washington DC, October 2018.
The Decipher Prostate Cancer classifier correlates with CAPRA-S in a high-risk group of African-American and Caucasian Patients. Alger J, Beamer M, Gadalla R, Nissim H, Stamatakis L, Krasnow R, Kowalczyk KJ, Hwang J. AUA Annual Meeting, San Francisco CA, May 2018.
Metabolic biomarkers are predictive of response to radiation therapy in prostate cancer patients. Cheema A, Grindrod S, Suy S, Zhong X, Jain S, Mehta K, Bandi G, Kowalczyk KJ, Lynch J, Collins S, Dritschilo A. AUA Annual Meeting, San Francisco CA, May 2018.
Complications associated with post-nephrectomy tyrosine kinase inhibitor use: results from SEER-Medicare. Carvalho FL, Zheng C, Witmer K, Jeng S, O’Neill J, Lynch JH, Kowalczyk KJ. AUA National Meeting, San Diego CA, May 2016
Outcomes and costs following treatment for locally advanced prostate cancer: Results from SEER-Medicare. Sussman R, Harbin A, Lynch J, Hu JC, Kowalczyk KJ. AUA National Meeting, New Orleans LA, 2015
Secondary Interventions After Treatment for Locally Advanced Prostate Cancer. Sussman R, Harbin A, Lynch J, Hu JC, Kowalczyk KJ. MAAUA Annual Meeting, Baltimore MD, 2014
Trends in treatment for men with clinically high-risk prostate cancer from 1995-2007: Results from SEER-Medicare. Harbin A, Sussman R, Lynch J, Hu JC, Kowalczyk KJ. AUA Annual Meeting, Orlando FL, 2014
Multi-institutional Predictors of Gleason Score Upgrading in a Large African-American Population. Vora AA, Large T, Aronica J, Haynes S, Harbin AC, Marchalik D, Nissim H, Lynch JH, Bandi G, McGeagh KM, Kowalczyk KJ, Ghasemian SR, Venkatesen K, Verghese M, Hwang JJ. AUA Annual Meeting, San Diego CA, May 2013.
Correlation of Prognostic Molecular Markers (ERG expression, PTEN delation, and HOXD3 promotor hypermethylation) with Clinical and Pathologic Features in Screening Prostate Biopsies. Rubin R, Chen L, Bandi G, McGeagh K, Pahira H, Collins S, Suy S, Kowalczyk KJ, Lynch JH. AUA Annual Meeting, San Diego CA, May 2013.
Multi-institutional Outcomes and Cost-Effectiveness of Using Alvimopan to Lower GI Morbidity After Cystectomy and Urinary Diversion. Vora AA, Rayson R, Harbin AC, Bandi G, McGeagh KM, Kowalczyk KJ, Lynch JH, Ghasemian SR, Venkatesen K, Hwang JJ, Verghes M. AUA Annual Meeting, San Diego CA, May 2013.
Optimal timing of early vs. delayed adjuvant radiation therapy for locally advanced prostate cancer. Kowalczyk KJ, Gu X, Nguyen PL, Lipsitz SR, Yu HY, Collins SP, Hu JC. AUA Annual Meeting, Atlanta GA, May 2012.
Radiotherapy following prostatectomy does not impact bone-related events in patients with node-positive prostate cancer. Kaplan J, Kowalczyk KJ, Borza T, Gu X, Nguyen PL, Yu HY, Hu JCAUA Annual Meeting, Atlanta GA, May 2012.
Influence of Surgeon and Hospital Volume on Radical Prostatectomy Costs. Kowalczyk KJ, Williams SB, Amarasekara CA, Gu X, Lipsitz SR, Nguyen PL, Hu JC. New England and Mid-Atlantic AUA Joint Annual Meeting, Orlando FL, 2011.
The Impact of Prostate Size, Median Lobe, and Prior Benign Prostatic Hyperplasia Intervention on Robotic-Assisted Radical Prostatectomy: Technique and Outcomes. Kowalczyk KJ, Huang AC, Hevelone ND, Lipsitz SR, Yu HY, Plaster BA, Amarasekara CA, Ulmer WD, Williams SB, Hu JC. New England and Mid-Atlantic AUA Joint Annual Meeting, Orlando FL, 2011.
Adjuvant vs. Salvage Radiation Therapy Following Prostatectomy for Locally Advanced Prostate Cancer: Results from SEER-Medicare. Kowalczyk KJ, Gu X, Yu H, Nguyen PL, Hu JC. AUA Annual Meeting, Washington DC, 2011.
Robotic-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy for Locally Advanced Prostate Cancer: A Comparison of Oncologic Outcomes. Kowalczyk KJ, Vora AA, Christiansen KA, Nissim H, Lynch JH, Ghasemian SR, Verghese M, Uchio E, Hwang JJ. MAAUA Annual Meeting, Nemacolin PA, 2010.
The Transobturator Male Sling for Post-Prostatectomy Incontinence: A Single-Institution's Initial Experience. Kowalczyk KJ, Laviana AA, Richter LA, Hwang JJ, Lynch JH, McGeagh KG. MAAUA Annual Meeting, Nemacolin PA, 2010.
Improving Urinary Continence in Robotic Prostatectomy: A Novel Urethral Plate Suspension Suturing (UPSS) Technique. Hwang JJ, Stisser B, Kowalczyk KJ, Ghasemian SR, Lynch JH, McGeagh KG, Verghese M, Uchio E. MAAUA Annual Meeting, Nemacolin PA, 2010.
Robotic-Assisted Laparoscopic Prostatectomy for Locally Advanced Prostate Cancer. Kowalczyk KJ, Vora AA, Christiansen KA, Lynch JH, Ghasemian SR, and Hwang JJ. Society of Urologic Oncology Annual Meeting, Bethesda MD, 2009.
Robotic Assisted Laparoscopic Partial Nephrectomy: A Review of Surgical Outcomes from a Single Institution's Initial Experience. Christiansen KA, Kowalczyk KJ, Lynch JH, Verghese M, Ghasemian SR, and Hwang JJ. MAAUA Annual Meeting, Williamsburg VA, 2009.
Routine Ureteral Frozen Section Examination at The Time of Radical Cystectomy: Utility and Cost-Effectiveness. Kowalczyk KJ, Christiansen KA, Lynch JH, Verghese M, Ghasemian SR, and Hwang JJ. AUA Annual Meeting, Chicago IL, 2009.
Ureteral Frozen Section At The Time Of Radical Cystectomy: Is It Always Necessary? Kowalczyk KJ, Verghese M, Ghasemian SR, and Hwang JJ. MAAUA Annual Meeting, Columbia MD, 2008.
Outcomes of Partial Nephrectomy after Previous Radiofrequency Ablation: The NCI Experience. Kowalczyk KJ, Hooper HB, Linehan WM, Wood BJ, Pinto PA, and Bratslavsky G. AUA Annual Meeting, Orlando FL, 2008.
Video Abstracts
Hemorrhagic Complications of Laparoscopic and Robotic Renal and Adrenal Surgery: When to Convert. Liu N, Khurana K, Kowalczyk KJ, Hooper HB, Bratslavsky G, and Pinto PA. AUA Annual Meeting, Orlando FL, 2008.